Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first line chemotherapy, in advanced breast cancer.

被引：0

作者：

Fountzilas, G ^{[1
]}

Papadimitriou, C ^{[1
]}

Bafaloukos, D ^{[1
]}

Skarlos, D ^{[1
]}

Kalofonos, HP ^{[1
]}

Aravantinos, G ^{[1
]}

Papakostas, P ^{[1
]}

Kosmidis, P ^{[1
]}

Pavlidis, N ^{[1
]}

Dimopoulos, MA ^{[1
]}

机构：

[1] Hellen Cooperat Oncol Grp, Data Off, Athens, Greece

来源：

ANNALS OF ONCOLOGY | 2000年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

104O

引用

页码：26 / 26

页数：1

共 50 条

[1] Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
Razis, E
Dimopoulus, AM
Bafaloukos, D
Papadimitriou, C
Kalogera-Fountzila, A
Kalofonos, H
Briassoulis, E
Samantas, E
Keramopoulos, A
Pavlidis, N
Kosmidis, P
Fountzilas, G
[J]. CANCER INVESTIGATION, 2001, 19 (02) : 137 - 144
[2] Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group
Fountzilas, G
Papadimitriou, C
Dafni, U
Bafaloukos, D
Skarlos, D
Moulopouos, LA
Razis, E
Kalofonos, HP
Aravantinos, G
Briassoulis, E
Papakostas, P
Abela, K
Gogas, E
Kosmidis, P
Pavlidis, N
Dimopoulos, MA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2232 - 2239
[3] Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer
Fountzilas, G
Papadimitriou, C
Aravantinos, G
Nicolaides, C
Stathopoulos, G
Bafaloukos, D
Kalofonos, H
Ekonomopoulos, T
Skarlos, D
Pavlidis, N
Dimopoulos, AM
[J]. ONCOLOGY, 2001, 60 (03) : 214 - 220
[4] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
Natoli, C.
Cianchetti, E.
Ficorella, C.
Angelucci, D.
Grossi, S.
Noccioli, P.
Ricevuto, E.
Grassadonia, A.
Zilli, M.
Di Giacobbe, A.
Rispoli, A., I
Tinari, N.
Iacobelli, S.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
[5] Dose-dense neoadjuvant chemotherapy in breast cancer.
Catane, R
Kaufman, B
Zach, L
Wolf, I
Gluck, I
Modiano, T
Barsuk, D
Shabtai, M
Papa, M
Paluch-Shimon, S
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 79S - 79S
[6] Bevacizumab with dose-dense paclitaxel/carboplatin as first-line chemotherapy for advanced ovarian cancer
Zhang, Li
Zhou, Qi
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 837 : 64 - 71
[7] DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF VERSUS EPIRUBICIN, CMF AND WEEKLY DOCETAXEL OR PACLITAXEL FOLLOWED BY TRASTUZUMAB FOR ONE YEAR IN PATIENTS WITH EARLY BREAST CANCER
Fountzilas, G.
Gogas, H.
Pavlidis, N.
Eleftheraki, A.
Skarlos, D.
Koutras, A.
Timotheadou, E.
Papandreou, C.
Pectasides, D.
Dimopoulos, M.
[J]. ANNALS OF ONCOLOGY, 2012, 23 : 95 - 95
[8] Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in patients with operable breast cancer and ≥10 positive axillary nodes
Fountzilas, G
Dimopoulos, M
Papadimitriou, C
Aravantinos, G
Briassoulis, E
Bafaloukos, D
Papakostas, P
Pavlidis, N
Skarlos, D
[J]. ANNALS OF ONCOLOGY, 1998, 9 : 179 - 179
[9] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.
Cramer, EM
Moers, C
Zarghooni, V
Mallmann, P
Warm, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 82S - 82S
[10] Neoadjuvant chemotherapy with a dose-dense and sequential combination of epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III breast cancer.: A phase II and pharmacogenomic study.
Sánchez-Rovira, P
Sánchez, A
Ribelles, A
Dueñas, B
Cidraque, M
Dueñas, R
Jaén, A
Martinez, E
Medina, B
Carrasco, E
Lozano, A
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S108 - S109

← 1 2 3 4 5 →